MK-7240

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-7240, covering 2026-04-08 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MK-7240 in Healthy Participants (MK-7240-009) [Phase 1]